Annual report
4502.TEDINET S100OBQE
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.57T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥3.20T | 2020-04-01 → 2021-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥3.29T | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.10T | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.77T | 2017-04-01 → 2018-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥460.8bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥509.3bn | 2020-04-01 → 2021-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥302.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥366.2bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥60.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥127.6bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥217.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥230.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥376.0bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥44.2bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥135.2bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥186.9bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥230.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥376.2bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥44.3bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥135.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥186.7bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥13.18T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥12.91T | at 2021-03-31 | Cons. | Assets IFRS |
| Total assets | ¥12.82T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥13.79T | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥4.11T | at 2018-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥7.49T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.74T | at 2021-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥5.68T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥5.18T | at 2021-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥4.73T | at 2020-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥5.68T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥5.17T | at 2021-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥849.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥966.2bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥637.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥702.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥294.5bn | at 2018-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥1.12T | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.01T | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥669.8bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥328.5bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥377.9bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥198.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥393.5bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥292.1bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.84T | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥93.3bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.07T | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.09T | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.01T | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥2.95T | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥326.2bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥147.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥240.72 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥28.41 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥140.61 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥239.35 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥145.87 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥238.96 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥28.25 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥139.82 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥237.56 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥3,665.61 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,308.93 | at 2021-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,032.22 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,332.94 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,556.51 | at 2018-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 43.1% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2021-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 36.8% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2018-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 0.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.6% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 47,347 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 47,099 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 47,495 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 49,578 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 27,230 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥764.3bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥602.6bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥616.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥651.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥659.5bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥293.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥121.1bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥550.9bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥50.0bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥72.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.5bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥125.9bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥371.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥235.5bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥324.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥247.5bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥130.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥88.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥187.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.64T | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥10.86T | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥10.29T | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.53T | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.95T | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.35T | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.42T | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.29T | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.43T | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.55T | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.65T | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.57T | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥287.1bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥274.0bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥207.5 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.45 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.88 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.76 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥239.47 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥207.5 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥158.44 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.87 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥91.72 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥239.18 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥180 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,769.31 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,835.81 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,919.21 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,987.94 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,002.29 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.7% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.1% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,582,253,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,388,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,374,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,565,006,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 794,688,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 5,149 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 4,966 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 5,350 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 5,291 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 5,461 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2022-03-31 | 47347 pure |
| Pharmaceutical Businessreportable segment | employees | at 2022-03-31 | 5149 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,724
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)目 加 田 雅 洋 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)野 中 浩 哲 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)難 波 宏 暁 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)米国におけるメディケイド、メディケア及びコマーシャル・マネージドケア・プログラムに関するリベートの引当金の見積りの合理性 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表の「注記３ 重要な会計方針」及び「注記23 引当金」 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)のれんの評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)連結財務諸表の「注記３ 重要な会計方針」及び「注記11 のれん」 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)目 加 田 雅 洋 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)野 中 浩 哲 | |
| Cpa3 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)難 波 宏 暁 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)繰延税金資産の回収可能性に関する判断の妥当性 | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項（重要な会計上の見積り）及び（税効果会計関係） | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior4YearDuration | 1770531000000 | JPY |
| Revenue IFRS (5-year summary) | Prior3YearDuration | 2097224000000 | JPY |
| Revenue IFRS (5-year summary) | Prior2YearDuration | 3291188000000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 3197812000000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYearDuration | 3569006000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior4YearDuration | 217205000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior3YearDuration | 127612000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior2YearDuration | -60754000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 366235000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYearDuration | 302571000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior4YearDuration | 186708000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior3YearDuration | 135080000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior2YearDuration | 44290000000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YearDuration | 376171000000 | JPY |
| Profit loss IFRS (5-year summary) | CurrentYearDuration | 230166000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior4YearDuration | 186886000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | 135192000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | 44241000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 376005000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | 230059000000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior4YearDuration | 242664000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |